HIV and cervical cancer prevention at the Hope Center in Kenya
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)
This project works to improve cervical cancer screening, follow-up, and treatment for women living with HIV in Nairobi to help catch and treat cancer earlier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11399252 on NIH RePORTER |
What this research studies
This project is based at the Coptic Hope Center in Nairobi and builds on long-standing cervical cancer screening of women living with HIV there. Researchers will strengthen the full prevention pathway from screening to diagnosis to timely treatment and will run clinical activities and trials at the site to test practical ways to close care gaps. Women in care may be offered enhanced screening, closer follow-up, linkage to treatment, and opportunities to provide clinical data or samples for research. The team aims to learn which service approaches most reliably prevent advanced cervical cancer among women with HIV in this setting.
Who could benefit from this research
Good fit: Ideal candidates are women living with HIV who receive care at the Coptic Hope Center or affiliated clinics in Nairobi, Kenya.
Not a fit: Women who are not living with HIV or who live outside the participating clinics in Kenya are unlikely to be able to take part or directly benefit from this project.
Why it matters
Potential benefit: If successful, the work could increase early detection and treatment of cervical precancer and cancer among women living with HIV, lowering morbidity and deaths.
How similar studies have performed: Integrated cervical cancer screening and treatment programs in low-resource settings have shown promising reductions in late-stage diagnoses, though optimizing care specifically for women with HIV remains an active area of work.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.